Belgium· BE-AMP-SAM662287-00
Tardyneo 20 mg/ml
A ferrous sulfate product containing ferrous sulfate heptahydrate, registered in Belgium by Pierre Fabre Médicament. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ferrous sulfate is registered in 10 of 19 countries.
Countries holding a registration under ATC B03AA07 (ferrous sulfate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Ferrous sulfate · ATC B03AA07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of ferrous sulfate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ferrous sulfate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.77
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ferrous Sulfate Heptahydrate
- Manufacturer
- Pierre Fabre Médicament
- Country
- Belgium (BE)
- ATC code
- B03AA07
- ATC class
- Ferrous sulfate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for ferrous sulfate.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ferrous sulfate · interactions on record
80 records
- 3 severe
- 68 moderate
- 7 minor
Most severe, free to view
- DolutegravirJ05AJ03severe
- DolutegravirJ05AX12severe
- DimercaprolV03AB09severe
- Magnesium carbonateA02AA01moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ferrous sulfate in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceTARDYFERON 20 mg/mL ENFANTS ET ADULTES, solution buvablePIERRE FABRE MEDICAMENT
- PolandTardysolPierre Fabre Medicament
- United KingdomActiFerr-S 200mg tabletsMaN Pharma Ltd
- United StatesFerrous SulfateRichmond Pharmaceuticals Inc.
- NorwayDuroferonPerrigo Sverige AB
- FinlandMicroferPfizer Health Ab
- GermanyEisensulfat LomapharmLomapharm Gmbh
- ItalyFERRO-GRAD*40 cpr 105 mg rilascio prolungatoTEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Ferro - Gradumet
- Germany · Eisensulfat Lomapharm, Ferro Aiwa
- Spain · Ferogradumet
- France · Fer Nouveau-Ne Ap-Hp
- United Kingdom (Northern Ireland) · Feospan, Ferrous Sulfate Wockhardt Uk
- Greece · Tardyferon
- Hungary · Ferro-Gradumet
- Lithuania · Tardyferon
- Luxembourg · Fero-Gradumet
- Norway · Duroferon, Ferromax
- Portugal · Ferro-Gradumet
- Slovakia · Tardyferon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f287d077-0253-4805-83ea-9452503fbf61 GET /v1/drugs/f287d077-0253-4805-83ea-9452503fbf61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tardyneo 20 mg/ml",
"name_fr": "Tardyneo 20 mg/ml",
"name_nl": "Tardyneo 20 mg/ml",
"amp_code": "SAM662287-00",
"strengths": [
"99.5600",
"99.5600",
"20.0000",
"20.0000",
"2.0000",
"1.5000",
"500.0000"
],
"pack_count": 1,
"substances": [
"Ferrous Sulfate Heptahydrate",
"Iron",
"Saccharin Sodium",
"Sodium Propionate",
"Sorbitol Liquid Non-Crystallising"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ferrous Sulfate",
"authorisation_numbers": [
"BE662287"
]
}See everything about ferrous sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.